Earnings estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 1.95 | 2.57 | 10.37 | 11.64 |
Low estimate | 1.78 | 2.29 | 10.14 | 10.54 |
High estimate | 2.13 | 2.79 | 10.88 | 12.29 |
Year ago EPS | 3 | 2.33 | 11.78 | 10.37 |
Revenue estimate | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
No. of analysts | 5 | 5 | 6 | 6 |
Avg. Estimate | 640.62M | 664.96M | 2.65B | 2.79B |
Low estimate | 624.8M | 642.3M | 2.61B | 2.74B |
High estimate | 656.49M | 683.6M | 2.69B | 2.84B |
Year ago sales | 697.96M | 632.1M | 2.67B | 2.65B |
Sales growth (year/est) | -8.20% | 5.20% | -0.70% | 5.10% |
Earnings history | 29/06/2023 | 29/09/2023 | 30/12/2023 | 30/03/2024 |
---|---|---|---|---|
Est. EPS | 2.68 | 2.78 | 2.82 | 2.15 |
Actual EPS | 3 | 2.33 | 3.1 | 2.29 |
Difference | 0.32 | -0.45 | 0.28 | 0.14 |
Surprise % | 11.90% | -16.20% | 9.90% | 6.50% |
EPS trend | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Current estimate | 1.95 | 2.57 | 10.37 | 11.64 |
7 days ago | 2.29 | 2.59 | 10.56 | 12 |
30 days ago | 2.29 | 2.59 | 10.56 | 12 |
60 days ago | 2.49 | 2.75 | 10.7 | 12.15 |
90 days ago | 2.92 | 2.81 | 11.57 | 13.16 |
EPS revisions | Current qtr. (Jun 2024) | Next qtr. (Sep 2024) | Current year (2024) | Next year (2025) |
---|---|---|---|---|
Up last 7 days | N/A | 1 | N/A | 1 |
Up last 30 days | N/A | 1 | N/A | 1 |
Down last 7 days | N/A | N/A | N/A | N/A |
Down last 30 days | 5 | 4 | 5 | 2 |
Growth estimates | BIO | Industry | Sector(s) | S&P 500 |
---|---|---|---|---|
Current qtr. | -35.00% | N/A | N/A | N/A |
Next qtr. | 10.30% | N/A | N/A | N/A |
Current year | -12.00% | N/A | N/A | N/A |
Next year | 12.20% | N/A | N/A | N/A |
Next 5 years (per annum) | 17.80% | N/A | N/A | N/A |
Past 5 years (per annum) | 13.82% | N/A | N/A | N/A |